Citation: Arosh S. Perera Molligoda Arachchige. Neuroimaging with SPECT-MRI: a myth or reality?[J]. AIMS Neuroscience, 2023, 10(1): 52-55. doi: 10.3934/Neuroscience.2023004
[1] | Hutton BF, Occhipinti M, Kuehne A, et al. (2018) Development of clinical simultaneous SPECT/MRI. Brit J Radiol 91: 20160690. https://doi.org/10.1259/bjr.20160690 |
[2] | Yandrapalli S, Puckett Y (2022) SPECT Imaging - StatPearls - NCBI Bookshelf.SPECT Imaging - StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK564426/ |
[3] | Amen DG, Easton M (2021) A New Way Forward: How Brain SPECT Imaging Can Improve Outcomes and Transform Mental Health Care Into Brain Health Care. Front Psychiatry 12: 715315. https://doi.org/10.3389/fpsyt.2021.715315 |
[4] | Bernsen MR, Vaissier PEB, Van Holen R, et al. (2014) The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI. Eur J Nucl Med Mol Imaging 41: 36-49. https://doi.org/10.1007/s00259-013-2685-3 |
[5] | Algahtany M, Abdrabou A, Elhaddad A, et al. (2021) Advances in Brain Imaging Techniques for Patients With Intractable Epilepsy. Front Neurosci 15: 699123. https://doi.org/10.3389/fnins.2021.699123 |
[6] | MRS*SPECT/CT/MR -MR Solutions. (n.d.). MRS*SPECT/CT/MR -MR Solutions . https://www.mrsolutions.com/molecular-imaging/molecular-imaging/spect-ct-mr/ |
[7] | Schneider A, Feussner H (2017) Diagnostic Procedures. Biomed Eng Gastrointest Surg : 87-220. https://doi.org/10.1016/b978-0-12-803230-5.00005-1 |
[8] | Bonte FJ, Ross ED, Chehabi HH, et al. (1986) SPECT study of regional cerebral blood flow in Alzheimer disease. J Comput Assist Tomo 10: 579-583. https://doi.org/10.1097/00004728-198607000-00005 |
[9] | Mortezazadeh T, Seyedarabi H, Mahmoudian B, et al. (2021) Imaging modalities in differential diagnosis of Parkinson's disease: opportunities and challenges. Egypt J Radiol Nucl Med 52: 79. https://doi.org/10.1186/s43055-021-00454-9 |
[10] | Booth TC, Nathan M, Waldman AD, et al. (2015) The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1. AJNR. Am J Neuroradiol 36: 229-235. https://doi.org/10.3174/ajnr.A3970 |
[11] | Kauppinen RA, Peet AC (2011) Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches. Cancer Biol Ther 12: 665-679. https://doi.org/10.4161/cbt.12.8.18137 |
[12] | Amen DG, Trujillo M, Newberg A, et al. (2011) Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool. Open Neuroimag J 5: 40-48. https://doi.org/10.2174/1874440001105010040 |
[13] | Son H, Jang K, Lee H, et al. (2019) Use of Molecular Imaging in Clinical Drug Development: a Systematic Review. Nucl Med Molec Imag 53: 208-215. https://doi.org/10.1007/s13139-019-00593-y14 |
[14] | Lystad RP, Pollard H (2009) Functional neuroimaging: a brief overview and feasibility for use in chiropractic research. J Can Chiropr Assoc 53: 59-72. |
[15] | Bouziotis P, Fiorini C (2014) SPECT/MRI: dreams or reality?. Clin Transl Imaging 2: 571-573. https://doi.org/10.1007/s40336-014-0095-6 |
[16] | Arachchige ASPM (2022) 7-Tesla PET/MRI: A promising tool for multimodal brain imaging?. AIMS Neurosci 9: 516-518. https://doi.org/10.3934/Neuroscience.2022029 |
[17] | Breton E, Choquet P, Goetz C, et al. (2007) Dual SPECT/MR imaging in small animal. Nucl Instrum Methods Phys Res A 571: 446-448. https://doi.org/10.1016/j.nima.2006.10.131 |